[
    [
        {
            "time": "2019-07-02",
            "original_text": "智飞生物预计2019上半年净利润同期上升55%～85%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "净利润",
                    "上升",
                    "2019上半年"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物预计2019上半年净利润同期上升55%～85%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-02",
            "original_text": "智飞生物：2019年半年度业绩报告预告",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2019年",
                    "半年度",
                    "业绩报告"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物：2019年半年度业绩报告预告",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-02",
            "original_text": "智飞生物：上半年净利预增55%-85%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "净利",
                    "预增",
                    "55%",
                    "85%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：上半年净利预增55%-85%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-02",
            "original_text": "智飞生物：预计上半年净利润10.58亿-12.62亿元，同比增长55%-85%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "净利润",
                    "10.58亿",
                    "12.62亿元",
                    "同比增长",
                    "55%",
                    "85%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：预计上半年净利润10.58亿-12.62亿元，同比增长55%-85%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-02",
            "original_text": "智飞生物：代理品种快速放量 买入评级",
            "features": {
                "keywords": [
                    "智飞生物",
                    "代理品种",
                    "快速放量",
                    "买入评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：代理品种快速放量 买入评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-02",
            "original_text": "【医药-智飞生物(300122)】江琦：2019H1预告点评：符合预期，4价和9价HPV疫苗放量推动公司业绩快速增长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2019H1",
                    "预告点评",
                    "4价",
                    "9价",
                    "HPV疫苗",
                    "放量",
                    "快速增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药-智飞生物(300122)】江琦：2019H1预告点评：符合预期，4价和9价HPV疫苗放量推动公司业绩快速增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]